Formulation: A neat solid
Pricing updated 2018-05-26. Prices are subject to change without notice.
Acetyl fentanyl (hydrochloride) is a mu opioid receptor agonist (EC50 = 676 nM in vitro) with receptor binding properties similar to that of morphine.1 It is a known process impurity in the synthesis of the opioid analgesic, fentanyl (EC50 ~30 nM).2,3,4 This product is intended for forensic and research applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.
Warning - this product is not for human or veterinary use.
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GC-MS spectra of many of Cayman's emerging forensic drug standards
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
1. Woods, J., Medzihradsky, F., Smith, C., et al. Evaluation of new compounds for opioid activity: 1987 Annual report. 81, 543-590 (1988).
2. Garg, A., Solas, D.W., Takahashi, L.H., et al. Forced degradation of fentanyl: Identification and analysis of impurities and degradants. Journal of Pharmaceutical & Biomedical Analysis 53(3), 325-334 (2010).
Brine, G.A., Boldt, K.G., Huang, P.T., et al. Carbon-
4. Bovill, J.G., Sebel, P.S., and Stanley, T.H. Opioid analgesics in anesthesia: With special reference to their use in cardiovascular anesthesia. Anesthesiology 61, 731-755 (1984).
Watanabe, S., Vikingsson, S., Roman, M., et al. In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-